Frequently asked questions

Get answers to your questions

Below you will find a list of the most common questions we receive. If your question is not on the list, please contact us or use some of the other contact options.

MR af prostata

Progardia Healthcare can offer an appointment for an MRI scan within a week.

Du får svar på MR-scanning af prostata inden for 2-5 dage. Ved svar på en biopsi, kan der gives svar indenfor 5-7 dage.

Progardia Healthcare tilbyder aktiv overvågning med PSA-test og MR-scanning i tilfælde af lav risiko prostatakræft. Ved aktiv MR-overvågning gives 20% rabat på MR-undersøgelsesprisen.

Progardia Healthcare has affiliated specialists in urinary tract surgery, radiology and general medicine. Radiographers and medical secretaries are also affiliated.

Yes, we have an agreement with the public health system in relation to "The extended free choice of hospital". If you are referred for an MRI scan, where the waiting time is more than 4 weeks, you are entitled via the regional visitation, to be referred to us.

Det er en ambition for Progardia Healthcare at få samarbejdsaftaler med det offentlige også til udredning for prostatakræft. 

The PSA level will be used in a later valuation of the screening value.

Netop fordi vi ikke tager biopsi før en MR-scanning rejser mistanke til prostatacancer, vil der blive udført langt færre biopsier, end uden en forudgående MR-scanning. MR-scanning kan godt rejse mistanke om et område, hvor en efterfølgende biopsi afkræfter diagnosen prostatakræft, så det er ikke muligt helt at udelukke, at der vil blive taget biopsier på raske mænd.

Prostate cancer has a high incidence and mortality in Denmark and is thus an obvious disease to introduce screening for. Prostate cancer diagnosis is traditionally based on PSA measurement and biopsies of the prostate, which is associated with low sensitivity and specificity. Therefore, there would be many men in a screening program who would have to undergo unnecessary biopsies - with the genes it provides.

Another problem is that there is a high incidence of prostate cancer with a low risk of developing deadly prostate cancer. A large proportion of patients with very early stages will not die from the disease and thus have no benefit from being diagnosed, let alone receiving surgery or radiation therapy. There is a risk of inflicting some treatment complications on men who do not have severe prostate cancer.

Due to the above, it has been assessed in Denmark that the cost for the “healthy” is too high in relation to recommending screening.

MRI scan of prostate cancer provides the opportunity to partly avoid discomfort and complications for the diagnosis itself, but also the opportunity to monitor patients with low-risk disease instead of proceeding to treatment. This eliminates possible complications for the men who are not at risk of dying from prostate cancer, while at the same time giving them the opportunity to save the men who turn out to have aggressive prostate cancer.

MRI scanning is thus potentially the method on which national screening can be founded. Economy, capacity and experience with MRI will be crucial.

When answering an MRI of the prostate, you will get an appointment with our specialist in urology.
Answer to MRI of the whole body you will receive by telephone from our specialist in general medicine.
For other examinations, the result will be sent to your referring doctor, who will give you the answer.

All answers can be sent to the e-boks.

Before the MRI scan, we need to know your PSA number. PSA is measured by a blood test that you can have performed at Progardia Healthcare.
You can also ask your own doctor if you can get it at the doctor's office, or at the local hospital.

As you will have contrast fluid injected during the MRI examination, we must also know if you have been diagnosed with kidney disease.

Finally, before an examination at Progardia Healthcare, you must fill in a control form, which you will receive in your e-boks. The questions in the control form should ensure that there is nothing to prevent you from having an MRI scan.

If the tests show that it is prostate cancer, your doctor will also be notified according to your acceptance in the questionnaire.

Prostate cancer exists in varying degrees and certain types may never require treatment. Other types will later develop and require treatment, while the latter group will require treatment immediately.

If we find a prostate cancer requiring treatment, you will be referred for treatment at a public hospital. Progardia Healthcare also collaborates with private hospitals (for example Martini Klinik in Hamburg), which we can also refer to at your request.

In the case of a more peaceful form of prostate cancer, we can offer a control program with follow-up in the form of PSA tests and MRI scans, or you can be referred to a control program at a public hospital.

Progardia Healthcare uses 3T MR systems and B&K 5000 ultrasound systems.

Both systems is the most optimally technically possible.

The equipment is used by our specially trained radiographers, radiologists and urologists.

Progardia Healthcare conducts multi-parametric MRI examination of the prostate according to the latest international (and national) recommendations, currently PI-RADS version 2.1, which also sets standards for image interpretation and communication between the physicians involved.

In practice, there will be individual adaptation of the MRI scanning protocol, which best takes into account the scanner's technical possibilities in selected cases – e.g. with prosthetic hips.

At Progardia Healthcare, targeted biopsies are performed based of the MRI scans. Only men with suspected prostate cancer assessed on the MRI scan will need to have a biopsy performed.

We perform prostate biopsy sterile through the groin to avoid the risk of infection.

The MRI images are transferred to the ultrasound equipment to ensure that the area is accurately biopsied.

Investigation of prostate cancer by means of MRI scan and subsequent targeted biopsy has been shown in lottery experiments to be more accurate and at the same time more gentle than prostate biopsies alone. This has made the method the recommended form of investigation for prostate cancer in Danish and European guidelines.

Progardia Healthcare uses the latest equipment in MRI scanners and ultrasound scanners to examine for prostate cancer. The scans are described by radiologists with extensive experience from e.g. the university hospitals to interpret MRI scans of the prostate. Biopsies are performed by urinary tract surgeons with experience in targeted biopsy of the prostate based on MRI scans.

Ja, dine billeder skal blot overføres til Progardia, hvorefter vores radiologer vil klargøre billederne til biopsien.

MR af helkrop

Progardia Healthcare can offer an appointment for an MRI scan within a week.

Progardia Healthcare can respond to MRI scan within 2-5 days. When responding to a biopsy, an answer can be given within 5-7 days.

Progardia Healthcare has affiliated specialists in urinary tract surgery, radiology and general medicine. Radiographers and medical secretaries are also affiliated.

Yes, we have an agreement with the public health system in relation to "The extended free choice of hospital". If you are referred for an MRI scan, where the waiting time is more than 4 weeks, you are entitled via the regional visitation, to be referred to us.

Progardia Healthcare anvender et 3T MR-anlæg, som er det optimalt teknisk mulige.

The equipment is used by our specially trained radiographers, radiologists and urologists.

MR-vejledt fokuseret ultralyd (MRgFUS)

MRgFUS er en forkortelse for ”MR vejledt fokuseret ultralyd). Metoden udnytter, at når uskadelige ultralydsbølger fra 1.024 enkelte ultralydshoveder med stor præcision fokuseres i et enkelt brændpunkt, vil der afsættes tilstrækkelig energi til at opvarme hjerneområdet (få mm i diameter). Energien, der afsættes kan styres meget præcist. Dermed kan opvarmningen af hjerneområdet kontrolleres, så der inden en permanent skade og dermed effekt opnås, kan laves en midlertidig og kortvarig lammelse af området. Dette mindsker risikoen for, at der med behandlingen kommer utilsigtede bivirkninger. Det er således en behandling uden kirurgisk åbning af hud og kranie. Behandlingen foregår uden bedøvelse og med mulighed for beroligende og lidt smertestillende undervejs.

Rundt om i verden anvendes MRgFUS til flere ting, men primært til behandling af rystesyge (essentiel tremor) og Parkinsons sygdom, hvor rystelserne er det dominerende.

Patienter med rystesyge eller Parkinsons sygdom, hvor rystelserne er svære og hvor medicinsk behandling enten ikke har effekt eller hvor behandlingen har svære bivirkninger. Anden behandling som operation med indsættelse elektroder dybt i hjernen skal også overvejes.

Vores neurologer med speciale i bevægeforstyrrelser afgør, om du kan være kandidat til behandlingen. Du skal være meget plaget af dine rystelser, og du skal have prøvet medicinsk behandling.

Behandlingen foregår på Progardia MRgFUS, Teglgårdsparken 118, Middelfart.
I nyindrettede lokaler har vi installeret en MR scanner med tilhørende MRgFUS udstyr. Efter udredning af vores neurologer vil du få en tid til behandling. Før behandlingen fjernes alt hår på hovedet.

Behandlingen indledes med, at du i lokalbedøvelse får spændt en ramme fast på hovedet. På rammen påmonteres en gummimembran, som fyldes med køligt og gasfrit vand. Du vil derefter blive hjulpet over i MR scanneren, og efter nogle indledende planlægningsscanninger påbegyndes behandlingen. Først udføres en midlertidig prøvelæsion, og når det helt rigtige sted for behandlingen er fundet – svarende til det sted, hvor det har bedst effekt på dine gener med et minimum af bivirkninger. Herefter skrues der op for styrken og en permanent skade udvikles, hvorved det tilsigtede resultat af behandlingen opnås.

Som udgangspunkt gør behandlingen ikke ondt. Nogle synes, det er ubehageligt at ligge længe i scanneren. Andre føler smerte i hovedbunden, når der skrues op for MRgFUS apparatet. I begge tilfælde skal du blot sige til. Vi har en speciallæge i bedøvelse og smertelindring til stede, som altid vil prøve at gøre behandlingen så behagelig for dig som muligt.

Nogle oplever mindre bivirkninger som føleforstyrrelser i arme eller ben og svimmelhed. Der er ellers rapporteret meget få risici.

Hos ca. 75% af behandlede patienter var der effekt af behandlingen i mere end 5 år.

Vi har sammensat et team af danske specialister indenfor neurologi, neurokirurgi, neuroradiologi og neuroanæstesi til at udføre behandlingerne. Teamet består af:

Morten Blaabjerg, professor, overlæge, neurolog og specialist i bevægeforstyrrelser

Mathias Bode, overlæge, neurolog og specialist i bevægeforstyrrelser

Niels Sunde, overlæge, neurokirurg og specialist i funktionel neurokirurgi

Christian Bonde Pedersen, overlæge, klinisk lektor, neurokirurg og specialist kraniekirurgi

Frantz Rom Poulsen, professor, overlæge neurokirurg og specialist kraniekirurgi

Nicolai Hatting, overlæge, specialist i neuroanæstesiologi (bedøvelse og smertelindring)

Willy Krone, overlæge, specialist i neuroradiologi

Behandlingsforløbet koster 185.000 kr. + 6% i lovpligtig patientforsikring.

Det koster 1.300 kr. for neurologisk speciallægeundersøgelse, der skal vurdere, om du er kandidat til behandlingen. Beløbet vil blive fratrukket behandlingsprisen ved behandling.